Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Endocrinology Drugs Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Endocrinology Drugs Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Diabetes Drugs
      • 1.3.3 Testosterone Replacement Drugs
      • 1.3.4 Human Growth Hormone Drugs
      • 1.3.5 Thyroid Hormone Disorder Drugs
    • 1.4 Market Segment by Application
      • 1.4.1 Global Endocrinology Drugs Market Share by Application (2019-2025)
      • 1.4.2 Hospitals
      • 1.4.3 Commercial Laboratories
      • 1.4.4 Ambulatory Care Centres
      • 1.4.5 Other Setting
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Endocrinology Drugs Market Size
      • 2.1.1 Global Endocrinology Drugs Revenue 2014-2025
      • 2.1.2 Global Endocrinology Drugs Sales 2014-2025
    • 2.2 Endocrinology Drugs Growth Rate by Regions
      • 2.2.1 Global Endocrinology Drugs Sales by Regions 2014-2019
      • 2.2.2 Global Endocrinology Drugs Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Endocrinology Drugs Sales by Manufacturers
      • 3.1.1 Endocrinology Drugs Sales by Manufacturers 2014-2019
      • 3.1.2 Endocrinology Drugs Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Endocrinology Drugs Revenue by Manufacturers (2014-2019)
      • 3.2.2 Endocrinology Drugs Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Endocrinology Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.3 Endocrinology Drugs Price by Manufacturers
    • 3.4 Key Manufacturers Endocrinology Drugs Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Endocrinology Drugs Market
    • 3.6 Key Manufacturers Endocrinology Drugs Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Diabetes Drugs Sales and Revenue (2014-2019)
      • 4.1.2 Testosterone Replacement Drugs Sales and Revenue (2014-2019)
      • 4.1.3 Human Growth Hormone Drugs Sales and Revenue (2014-2019)
      • 4.1.4 Thyroid Hormone Disorder Drugs Sales and Revenue (2014-2019)
    • 4.2 Global Endocrinology Drugs Sales Market Share by Type
    • 4.3 Global Endocrinology Drugs Revenue Market Share by Type
    • 4.4 Endocrinology Drugs Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Endocrinology Drugs Sales by Application

    6 United States

    • 6.1 United States Endocrinology Drugs Breakdown Data by Company
    • 6.2 United States Endocrinology Drugs Breakdown Data by Type
    • 6.3 United States Endocrinology Drugs Breakdown Data by Application

    7 European Union

    • 7.1 European Union Endocrinology Drugs Breakdown Data by Company
    • 7.2 European Union Endocrinology Drugs Breakdown Data by Type
    • 7.3 European Union Endocrinology Drugs Breakdown Data by Application

    8 China

    • 8.1 China Endocrinology Drugs Breakdown Data by Company
    • 8.2 China Endocrinology Drugs Breakdown Data by Type
    • 8.3 China Endocrinology Drugs Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Endocrinology Drugs Breakdown Data by Company
    • 9.2 Rest of World Endocrinology Drugs Breakdown Data by Type
    • 9.3 Rest of World Endocrinology Drugs Breakdown Data by Application
    • 9.4 Rest of World Endocrinology Drugs Breakdown Data by Countries
      • 9.4.1 Rest of World Endocrinology Drugs Sales by Countries
      • 9.4.2 Rest of World Endocrinology Drugs Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 AbbVie
      • 10.1.1 AbbVie Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Endocrinology Drugs
      • 10.1.4 Endocrinology Drugs Product Introduction
      • 10.1.5 AbbVie Recent Development
    • 10.2 AstraZeneca
      • 10.2.1 AstraZeneca Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Endocrinology Drugs
      • 10.2.4 Endocrinology Drugs Product Introduction
      • 10.2.5 AstraZeneca Recent Development
    • 10.3 Eli Lilly
      • 10.3.1 Eli Lilly Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Endocrinology Drugs
      • 10.3.4 Endocrinology Drugs Product Introduction
      • 10.3.5 Eli Lilly Recent Development
    • 10.4 Merck
      • 10.4.1 Merck Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Endocrinology Drugs
      • 10.4.4 Endocrinology Drugs Product Introduction
      • 10.4.5 Merck Recent Development
    • 10.5 Novo Nordisk
      • 10.5.1 Novo Nordisk Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Endocrinology Drugs
      • 10.5.4 Endocrinology Drugs Product Introduction
      • 10.5.5 Novo Nordisk Recent Development
    • 10.6 Sanofi
      • 10.6.1 Sanofi Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Endocrinology Drugs
      • 10.6.4 Endocrinology Drugs Product Introduction
      • 10.6.5 Sanofi Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Endocrinology Drugs Sales Channels
      • 11.2.2 Endocrinology Drugs Distributors
    • 11.3 Endocrinology Drugs Customers

    12 Market Forecast

    • 12.1 Global Endocrinology Drugs Sales and Revenue Forecast 2019-2025
    • 12.2 Global Endocrinology Drugs Sales Forecast by Type
    • 12.3 Global Endocrinology Drugs Sales Forecast by Application
    • 12.4 Endocrinology Drugs Forecast by Regions
      • 12.4.1 Global Endocrinology Drugs Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Endocrinology Drugs Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Endocrinology drugs are used to treat hormonal problems such as hypothyroidism, diabetes and others.
      One of the market drivers is increase in prevalence of endocrine hormone-related diseases.
      In 2019, the market size of Endocrinology Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Endocrinology Drugs.

      This report studies the global market size of Endocrinology Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Endocrinology Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      AbbVie
      AstraZeneca
      Eli Lilly
      Merck
      Novo Nordisk
      Sanofi
      ...

      Market Segment by Product Type
      Diabetes Drugs
      Testosterone Replacement Drugs
      Human Growth Hormone Drugs
      Thyroid Hormone Disorder Drugs

      Market Segment by Application
      Hospitals
      Commercial Laboratories
      Ambulatory Care Centres
      Other Setting

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Endocrinology Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Endocrinology Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Endocrinology Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now